Aird & Berlis acted as Canadian legal counsel to Small Pharma.
On April 29, 2021, Small Pharma Inc. (TSXV: DMT) (formerly Unilock Capital Corp.) completed its acquisition of Small Pharma Ltd, a U.K.-based neuropharmaceutical company specialized in IP-led development of novel treatments for mental health conditions, and initial listing on the TSX Venture Exchange by way of a qualifying transaction under the TSXV Capital Pool Company program.
Small Pharma is a neuropharmaceutical company specialized in intellectual-property-led development of novel treatments for mental health conditions; in particular, depression.
The Aird & Berlis team included Richard Kimel (Picture), Melanie Cole, Danny Kharazmi, Sean Green (Capital Markets), Emily Chittick and Al Turnbull (Articling Students).
Law Firms: Aird & Berlis LLP;
Clients: Small Pharma Inc.;